New prospects in the conservative treatment of rectal cancer
Author:
- Jean PapillonJPJean Papillon
- 1 November 1984
- journal article
- research article
- Published by Wolters Kluwer Health in Diseases of the Colon & Rectum
- Vol. 27 (11) , 695-700
Abstract
Conservative treatment of rectal cancer is applicable only to limited tumors that are assumed to have no lymphatic spread; these are well or moderately well differentiated adenocarcinomas confined to the bowel wall, without palpable pararectal metastatic lymph nodes. The experience of intracavitary irradiation (contact x-ray therapy often combined with iridium 192 implant), based on 245 patients followed for more than five years, shows a low rate of local failure (5.3 per cent). The rate of death from cancer is 8.9 per cent and the five-year survival rate is 76 per cent. In patients under 60 years, a perirectal lymphadenectomy should be considered a safety measure. A new approach, based on a combination of external beam irradiation (3000 rads in 12 days), followed by iridium 192 implant two months later, allows the field of conservative treatment in poor-risk surgical patients to be extended without jeopardizing their chance of cure.Keywords
This publication has 7 references indexed in Scilit:
- Preoperative radiation therapy for rectal carcinomaDiseases of the Colon & Rectum, 1982
- The clinical staging of rectal cancerBritish Journal of Surgery, 1982
- Policy of local excision for early cancer of the colorectum.Gut, 1977
- Radiotherapy and rectal cancerCancer, 1977
- Preoperative radiotherapy for adenocarcinoma of the rectosigmoidCancer, 1976
- Clinical evaluation of electrocoagulation in the treatment of cancer of the rectumThe American Journal of Surgery, 1971
- Conservative management of selected patients with carcinoma of the rectumDiseases of the Colon & Rectum, 1961